Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Opposes Michigan HB 4812 Which Limits Biologic Drug Substitution AMCP Opposes Michigan HB 4812 Which Limits Biologic Drug Substitution 1/19/16 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page mi_hb_4812_biosimilars.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page